If the 2 doctors couldn't agree on 1 in 3 diagnosis results, wouldn't it have been smarter to scrap those patients from the study? The app should only be compared against 100% confirmed diagnosed patients or patients in the all clear. It should have never been compared against patients with an unclear diagnosis by the 2 doctors. Another alternative would be to bring in multiple doctors to get a majority vote on those results, not just one extra doctor who could swing either way.
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-196
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online